This study was designed to evaluate the prognostic significance of GLP1R expression across various cancer types, with the hypothesis that GLP1R expression might serve as an indicator of certain cancers’ sensitivity to glucagon/GLP-1 signaling. The gene discussed is GCG; the disease is cancer.